Psychedelic Stocks

2020-06-30 TSI Reporter

Numinus' new Clinical Advisory Council will provide support for its psychedelic drug R&D at all levels.

2020-06-30 TSI Reporter

Former Canada Health Minister joins Red Light Holland as Senior Advisor.

2020-06-30 TSI Editor

Wuhan General lines up capsule manufacturer, specializing in coffee pods.

2020-06-29 PSW Editor

Psychedelic drugs are an emerging sector with exciting investment potential. Here are some tips on beginning your due diligence.

2020-06-29 TSI Editor

Psychedelic drugs are an emerging sector with exciting investment potential. Here are some tips on beginning your due diligence.

2020-06-29 PSW Editor

Cybin Corp will become the latest psychedelics company to go public, via RTO.

2020-06-26 TSI Reporter

Empower's new wellness clinic in Vancouver will support development of its psychedelics division.

2020-06-25 TSI Editor

Numinus Wellness Inc. has assembled the licensing and personnel to be a significant player in psilocybin-based drug research.

2020-06-25 TSI Reporter

New psychedelics company specializing in psilocybin-based medical research has filed a prospectus.

2020-06-24 TSI Reporter

MindMed files patent applications for technologies to screen and optimize dosing of MDMA and LSD.

2020-06-22 Jeff Nielson

Psychedelics micro-dosing offers several key advantages over psychedelic drug applications centered around heavier dosages.

2020-06-19 Jeff Nielson

ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.